Published in Oncogene on February 02, 2006
CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel. J Virol (2008) 1.08
Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins. Cancer Res (2008) 0.89
Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family. Cancer Res (2009) 0.88
A thioredoxin fold protein Sh3bgr regulates Enah and is necessary for proper sarcomere formation. Dev Biol (2015) 0.84
OHMM: a Hidden Markov Model accurately predicting the occupancy of a transcription factor with a self-overlapping binding motif. BMC Bioinformatics (2009) 0.82
Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans. Oncogene (2015) 0.81
Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging. PLoS One (2015) 0.79
Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes. PLoS One (2012) 0.79
Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis. Oncogene (2010) 0.78
ERK and JNK activation is essential for oncogenic transformation by v-Rel. Oncogene (2010) 0.77
Expression patterns of SH3BGR family members in zebrafish development. Dev Genes Evol (2016) 0.75
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev (1991) 3.52
Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet (2001) 3.27
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci U S A (1992) 2.29
Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac Radiol (2010) 2.15
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus. Proc Natl Acad Sci U S A (1983) 2.11
Cleavage of a viral envelope precursor during the morphogenesis of Sindbis virus. J Virol (1974) 1.96
Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res (1991) 1.88
Isolation and characterization of reticuloendotheliosis virus transformed bone marrow cells. Intervirology (1974) 1.87
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des (2008) 1.82
Hematopoietic cell transformation by reticuloendotheliosis virus: characterization of the genetic defect. Virology (1980) 1.73
Relationship of reticuloendotheliosis virus to the avian tumor viruses: nucleic acid and polypeptide composition. J Virol (1973) 1.54
Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell (1981) 1.49
ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol (1997) 1.49
Homologous interference induced by Sindbis virus. J Virol (1974) 1.49
Transformation by reticuloendotheliosis virus: development of a focus assay and isolation of a nontransforming virus. Virology (1979) 1.47
Interaction of Sindbis virus glycoproteins during morphogenesis. J Virol (1977) 1.40
Risk of miscarriage and a common variant of the estrogen receptor gene. Am J Epidemiol (1993) 1.39
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res (1997) 1.36
Correlation of messenger RNA function with adenylate-rich segments in the genomes of single-stranded RNA viruses. Proc Natl Acad Sci U S A (1972) 1.36
Genome of reticuloendotheliosis virus: characterization by use of cloned proviral DNA. J Virol (1982) 1.36
Physiological studies of methane- and methanol-oxidizing bacteria: comparison of a primary alcohol dehydrogenase from Methylococcus capsulatus (Texas strain) and Pseudomonas species M27. J Bacteriol (1972) 1.35
An adenylate-rich segment in the virion RNA of Sindbis virus. Biochem Biophys Res Commun (1972) 1.35
Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J Med Genet (2003) 1.31
Group-specific antigen shared by the members of the reticuloendotheliosis virus complex. J Virol (1976) 1.26
Induction of stress proteins in Sindbis virus- and vesicular stomatitis virus-infected cells. Virology (1983) 1.24
Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet (2002) 1.23
Replication of the reticuloendotheliosis virus (strain T) in chicken embryo cell culture. J Virol (1967) 1.21
Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med (2010) 1.21
Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood (1998) 1.18
Separation of reticuloendotheliosis virus from avian tumor viruses. J Virol (1971) 1.18
Virus-directed post-translational cleavage in Sindbus virus-infected cells. J Virol (1977) 1.17
Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem (1996) 1.14
Selective association of Sindbis virion proteins with different membrane fractions of infected cells. J Virol (1972) 1.12
The v-rel oncogene product is complexed with cellular proteins including its proto-oncogene product and heat shock protein 70. Virology (1990) 1.10
Expression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells. Proc Natl Acad Sci U S A (1986) 1.10
Immunological activity associated with the nucleocapsid and envelope components of an arbovirus. J Virol (1970) 1.08
Transformation of chick embryo fibroblasts by reticuloendotheliosis virus. Virology (1977) 1.08
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
Phosphorylated proteins of Sindbis virus. J Virol (1974) 1.06
The v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells. Proc Natl Acad Sci U S A (1988) 1.06
An additional 136 SSLP markers typed for the AXB and BXA recombinant inbred mouse strains. Mamm Genome (1997) 1.04
Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res (1998) 1.03
The transforming protein of avian reticuloendotheliosis virus is a soluble cytoplasmic protein which is associated with a protein kinase activity. Virology (1987) 1.02
Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp Lung Res (2001) 1.02
Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis (1995) 1.02
Heavy metal contamination and distribution in the urban environment of Guangzhou, SE China. Environ Geochem Health (2006) 1.01
The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci U S A (1994) 1.00
Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res (2001) 1.00
Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res (1990) 1.00
Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect (1992) 0.99
At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice. Genomics (1998) 0.98
AP-1 factors play an important role in transformation induced by the v-rel oncogene. Mol Cell Biol (1998) 0.97
Expression of the v-rel oncogene in reticuloendotheliosis virus-transformed fibroblasts. Virology (1988) 0.97
Helper viruses associated with avian acute leukemia viruses inhibit the cellular immune response. Virology (1982) 0.96
The virus envelope in cell attachment. J Gen Virol (1970) 0.95
Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from Erythroxylum pervillei. J Nat Prod (2001) 0.95
Alterations within pp59v-rel-containing protein complexes following the stimulation of REV-T-transformed lymphoid cells with zinc. Virology (1992) 0.95
Oncogene expression in reticuloendotheliosis virus-transformed lymphoid cell lines and avian tissues. J Virol (1986) 0.94
Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics. J Virol (1995) 0.94
Identification of protein complexes containing the c-rel proto-oncogene product in avian hematopoietic cells. Oncogene (1990) 0.94
Contact-mediated suppression of mitogen-induced responsiveness by spleen cells in reticuloendotheliosis virus-induced tumorigenesis. Cell Immunol (1977) 0.94
Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis (1993) 0.94
Alterations in monovalent cation transport in Sindbis virus-infected chick cells. Virology (1984) 0.93
The role of monovalent cation transport in Sindbis virus maturation and release. Virology (1989) 0.93
Immunosuppression induced by avian reticuloendotheliosis virus: mechanism of induction of the suppressor cell. J Immunol (1979) 0.92
Rearrangement and diversification of immunoglobulin light-chain genes in lymphoid cells transformed by reticuloendotheliosis virus. Mol Cell Biol (1989) 0.91
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene (2006) 0.91
Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol Cell Biol (2001) 0.90
Acquisition of new proviral copies in avian lymphoid cells transformed by reticuloendotheliosis virus. J Virol (1989) 0.90
Effect of tunicamycin on the development of the cytopathic effect in Sindbis virus-infected avian fibroblasts. Virology (1985) 0.90
Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene (1996) 0.90
5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model. Carcinogenesis (1999) 0.90
Single nucleotide polymorphism (SNP) analysis of mouse quantitative trait loci for identification of candidate genes. J Med Genet (2004) 0.89
Separation of Sindbis virus plaque-type variants by calcium phosphate chromatography. Arch Gesamte Virusforsch (1970) 0.89
Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res (2000) 0.88
The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha. J Virol (1995) 0.88
K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis (1995) 0.88
Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines. Exp Lung Res (2001) 0.88
The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells of the B cell lineage in vitro. Virology (1991) 0.88
Expression of the c-rel and c-myc proto-oncogenes in avian tissues. Oncogene (1989) 0.87
Entropy and distance of random graphs with application to structural pattern recognition. IEEE Trans Pattern Anal Mach Intell (1985) 0.87
Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids. J Virol (1994) 0.86
Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res (1994) 0.85
Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene (1995) 0.85
Suppression of the mitogen-stimulated blastogenic response during reticuloendotheliosis virus-induced tumorigenesis: investigations into the mechanism of action of the suppressor. J Immunol (1978) 0.85
c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene (1997) 0.85
Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein. Oncogene (1997) 0.85
The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog (1994) 0.85
Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res (2000) 0.85
Quality of life among advanced breast cancer patients with and without distant metastasis. Eur J Cancer Care (Engl) (2012) 0.84
Depression of mitogen response in spleen cells from reticuloendotheliosis virus-infected chickens and their suppressive effect on normal lymphocyte response. J Immunol (1978) 0.84
Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Mol Carcinog (1999) 0.84
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Carcinogenesis (1998) 0.84
Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl (1997) 0.83
Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. Oncogene (2009) 0.83